MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-13-2025
DURECT Corporation ROA Ratio 2011-2026 | DRRX
Annual ROA Ratio DURECT Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -61.13 | -58.79 | -39.42 | -0.77 | -23.92 | -50.65 | -6.96 | -85.19 | -48.45 | -44.15 | -52.55 | 35.27 | -38.14 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.27 | -85.19 | -36.53 |
Quarterly ROA Ratio DURECT Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -77.82 | -80.77 | -56.81 | -61.98 | -70.13 | -52.64 | -50.74 | -41.22 | -30.54 | -40.72 | -33.83 | -42.44 | -27.52 | -39.86 | -42.01 | -14.45 | -6.53 | -11.45 | -1.43 | -28.79 | -23.92 | -33.6 | -36.72 | -42.34 | -50.65 | -20.54 | -3.61 | -8.27 | -6.96 | -44.21 | -77.52 | -81.08 | -85.19 | -75.94 | -68.0 | -57.46 | -48.45 | -47.82 | -48.11 | -47.33 | -44.15 | -44.78 | -45.38 | -47.04 | -52.55 | -52.03 | -47.73 | -44.54 | 35.27 | 42.89 | 43.13 | 41.89 | -38.14 | -10.21 | -10.66 | -12.92 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 43.13 | -85.19 | -35.83 |
ROA Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
-13.11 | - | - | $ 142 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-242.23 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-17.34 | - | - | $ 754 M | USA |
 |
Cronos Group
CRON
|
-3.8 | $ 2.66 | -0.56 % | $ 1.4 B |  Canada |
 |
Canopy Growth Corporation
CGC
|
-65.18 | $ 1.28 | 7.8 % | $ 138 M | Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
-71.31 | - | 7.5 % | $ 6.35 M | USA |
 |
Agile Therapeutics
AGRX
|
-141.05 | - | 10.11 % | $ 58.2 M | USA |
 |
Catalent
CTLT
|
-10.69 | - | - | $ 11.5 B | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-34.9 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-8.75 | - | 2.45 % | $ 38.1 M | Canada |
 |
Eagle Pharmaceuticals
EGRX
|
8.78 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
-47.69 | - | - | $ 28.9 M |  Irlanda |
 |
Emergent BioSolutions
EBS
|
-41.71 | $ 13.4 | -3.67 % | $ 686 M | USA |
 |
Evoke Pharma
EVOK
|
-110.24 | - | - | $ 36.6 M | USA |
 |
Athenex
ATNX
|
-50.69 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-29.73 | $ 21.48 | -0.09 % | $ 2.04 B |  France |
 |
Sundial Growers
SNDL
|
-16.12 | $ 1.65 | -0.3 % | $ 3.37 M | Canada |
 |
Evolus
EOLS
|
-21.68 | $ 5.72 | 0.97 % | $ 355 M | USA |
 |
Harrow Health
HROW
|
-7.82 | $ 50.59 | -0.81 % | $ 1.65 B | USA |
 |
China Pharma Holdings
CPHI
|
-31.81 | $ 1.39 | 2.21 % | $ 24.3 M |  China |
 |
Jupiter Wellness
JUPW
|
-673.3 | - | - | $ 33.6 M | USA |
 |
OrganiGram Holdings
OGI
|
-23.59 | $ 1.74 | 3.57 % | $ 402 M | Canada |
 |
Bausch Health Companies
BHC
|
-2.16 | $ 7.81 | -1.2 % | $ 2.85 B | Canada |
 |
Lannett Company
LCI
|
-47.81 | - | 1.15 % | $ 7.11 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-2.52 | $ 4.78 | -7.96 % | $ 67.2 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
6.13 | - | - | $ 193 M | Canada |
 |
Aurora Cannabis
ACB
|
-26.69 | $ 4.25 | 0.12 % | $ 86.3 M | Canada |
 |
Organogenesis Holdings
ORGO
|
0.17 | $ 4.25 | -1.28 % | $ 560 M | USA |
 |
Pacira BioSciences
PCRX
|
-6.41 | $ 26.09 | 0.35 % | $ 1.21 B | USA |
 |
PetIQ
PETQ
|
0.25 | - | 1.64 % | $ 400 M | USA |
 |
Perrigo Company plc
PRGO
|
-1.78 | $ 14.84 | 1.64 % | $ 2.04 B | USA |
 |
ProPhase Labs
PRPH
|
21.06 | - | - | $ 5.07 M | USA |
 |
Recro Pharma
REPH
|
-8.65 | - | -4.76 % | $ 65.3 M | USA |
 |
Radius Health
RDUS
|
-38.66 | - | - | $ 1.42 B | USA |
 |
Rockwell Medical
RMTI
|
-16.18 | $ 1.0 | 4.65 % | $ 23.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
-101.27 | $ 4.4 | 1.85 % | $ 132 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-25.25 | $ 3.82 | 1.33 % | $ 4.74 M | USA |
 |
OptiNose
OPTN
|
-32.94 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
-115.89 | $ 9.4 | -0.32 % | $ 668 M | USA |
 |
PLx Pharma
PLXP
|
-60.18 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-66.1 | $ 5.32 | -5.17 % | $ 217 M | USA |
 |
Tilray
TLRY
|
-33.73 | $ 9.13 | 1.57 % | $ 5.64 B | Canada |
 |
SCYNEXIS
SCYX
|
52.21 | $ 0.67 | 3.96 % | $ 32.1 M | USA |
 |
Tricida
TCDA
|
-104.78 | - | - | $ 3.25 M | USA |
 |
Veru
VERU
|
-62.57 | $ 2.32 | -2.11 % | $ 313 M | USA |
 |
TherapeuticsMD
TXMD
|
-23.73 | $ 2.01 | -1.62 % | $ 21 M | USA |
 |
cbdMD
YCBD
|
-1.44 | $ 1.1 | - | $ 4.74 M | USA |
 |
Viatris
VTRS
|
4.16 | $ 12.61 | 1.16 % | $ 15.3 B | USA |
 |
Zomedica Corp.
ZOM
|
-13.64 | - | -0.21 % | $ 98 M | USA |